Nuvectis Pharma Inc (NVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,260 | -15,638 | -9,757 | -4,049 | -19,085 |
| Other Working Capital | 1,601 | 49 | -1,455 | -2,130 | 3,819 |
| Other Operating Activity | 4,705 | 3,485 | 2,352 | 1,402 | 1,707 |
| Operating Cash Flow | $-15,954 | $-12,104 | $-8,860 | $-4,777 | $-13,559 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16,481 | 15,580 | 14,440 | 702 | 31,879 |
| Other Financing Activity | -1,394 | -1,410 | -973 | -450 | -4,069 |
| Financing Cash Flow | $15,087 | $14,170 | $13,467 | $252 | $27,810 |
| Beginning Cash Position | 19,993 | 19,993 | 19,993 | 19,993 | 5,742 |
| End Cash Position | 19,126 | 22,059 | 24,600 | 15,468 | 19,993 |
| Net Cash Flow | $-867 | $2,066 | $4,607 | $-4,525 | $14,251 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,954 | -12,104 | -8,860 | -4,777 | -13,559 |
| Free Cash Flow | -15,954 | -12,104 | -8,860 | -4,777 | -13,559 |